# JINS HOLDINGS Inc. (JNDOF)

> Healthcare · JP · Reports in JPY

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/JNDOF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | ¥ 80.79B | ¥ 6.25B | ¥ 0 | ¥ 7.78B | ¥ 35.73B |
| 2025 | ¥ 97.22B | ¥ 8.33B | ¥ 0 | ¥ 5.73B | ¥ 31.74B |
| 2024 | ¥ 83.00B | ¥ 4.67B | ¥ 1.42B | ¥ 12.37B | ¥ 25.59B |
| 2023 | ¥ 73.26B | ¥ 1.76B | ¥ 2.86B | ¥ 12.51B | ¥ 21.78B |
| 2022 | ¥ 66.90B | ¥ 750.00M | ¥ 1.51B | ¥ 22.82B | ¥ 20.41B |
| 2021 | ¥ 63.90B | ¥ 3.29B | ¥ 0 | ¥ 23.35B | ¥ 20.22B |
| 2020 | ¥ 59.84B | ¥ 1.68B | ¥ 0 | ¥ 24.52B | ¥ 17.76B |
| 2019 | ¥ 60.73B | ¥ 3.80B | ¥ 0 | ¥ 4.80B | ¥ 22.37B |
| 2018 | ¥ 54.27B | ¥ 3.06B | ¥ 0 | ¥ 4.24B | ¥ 19.71B |
| 2017 | ¥ 50.05B | ¥ 2.74B | ¥ 0 | ¥ 5.67B | ¥ 17.52B |
| 2016 | ¥ 46.29B | ¥ 1.98B | ¥ 0 | ¥ 5.62B | ¥ 15.23B |
| 2015 | ¥ 40.91B | ¥ 1.91B | ¥ 0 | ¥ 4.67B | ¥ 13.98B |
| 2014 | ¥ 36.41B | ¥ 1.25B | ¥ 0 | ¥ 3.68B | ¥ 12.42B |
| 2013 | ¥ 37.70B | ¥ 3.53B | ¥ 0 | ¥ 3.77B | ¥ 12.13B |
| 2012 | ¥ 23.70B | ¥ 1.14B | N/A | ¥ 3.77B | ¥ 8.95B |
| 2011 | ¥ 15.24B | ¥ 401.55M | ¥ -628.90M | ¥ 2.26B | ¥ 2.58B |
| 2010 | ¥ 11.06B | ¥ 242.65M | ¥ 685.02M | ¥ 951.78M | ¥ 2.24B |
| 2009 | ¥ 7.73B | ¥ -19.28M | ¥ -387.62M | ¥ 1.41B | ¥ 2.02B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.22 |
| Liabilities / Eq | 0.90 |
| Current Ratio | 1.26 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 2.09 |
| Gross Debt / FCF | 13.43 |

## Other views

- [Metrics](https://sponda.capital/en/JNDOF.md)
- [Charts](https://sponda.capital/en/JNDOF/charts.md)
- [Compare](https://sponda.capital/en/JNDOF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.
